Shares of Gerresheimer AG (ETR:GXI) have earned an average recommendation of “Hold” from the ten ratings firms that are covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is €70.93 ($82.48).
Several analysts have weighed in on the stock. JPMorgan Chase & Co. set a €56.40 ($65.58) target price on shares of Gerresheimer and gave the company a “sell” rating in a research note on Monday, October 7th. DZ Bank reiterated a “neutral” rating on shares of Gerresheimer in a research note on Friday. HSBC set a €85.00 ($98.84) target price on shares of Gerresheimer and gave the company a “buy” rating in a research note on Monday. Deutsche Bank set a €83.00 ($96.51) target price on shares of Gerresheimer and gave the company a “buy” rating in a research note on Monday. Finally, Berenberg Bank set a €81.00 ($94.19) target price on shares of Gerresheimer and gave the company a “buy” rating in a research note on Thursday, October 10th.
GXI stock traded up €2.70 ($3.14) during trading on Thursday, hitting €65.70 ($76.40). 144,829 shares of the company’s stock traded hands, compared to its average volume of 140,925. The company has a quick ratio of 0.56, a current ratio of 0.85 and a debt-to-equity ratio of 64.56. Gerresheimer has a 52 week low of €51.10 ($59.42) and a 52 week high of €74.80 ($86.98). The stock has a fifty day moving average price of €66.77 and a two-hundred day moving average price of €67.42. The stock has a market capitalization of $2.06 billion and a price-to-earnings ratio of 9.97.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Featured Article: Why are trading ranges significant?
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.